FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 30 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 2.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $214,035 | -72.6% | 28,500 | -67.8% | 0.00% | – |
Q2 2023 | $780,828 | -63.6% | 88,429 | -65.7% | 0.00% | – |
Q1 2023 | $2,144,230 | -20.2% | 257,720 | -7.9% | 0.00% | – |
Q4 2022 | $2,687,165 | +217.3% | 279,913 | +167.6% | 0.00% | – |
Q3 2022 | $847,000 | -33.7% | 104,600 | -53.8% | 0.00% | – |
Q2 2022 | $1,278,000 | +21.4% | 226,175 | +20.3% | 0.00% | – |
Q1 2022 | $1,053,000 | -41.8% | 188,064 | -54.2% | 0.00% | – |
Q4 2021 | $1,808,000 | +198.8% | 410,802 | +540.5% | 0.00% | – |
Q3 2021 | $605,000 | +62.2% | 64,142 | +25.5% | 0.00% | – |
Q2 2021 | $373,000 | +119.4% | 51,098 | +124.7% | 0.00% | – |
Q4 2020 | $170,000 | -51.6% | 22,736 | -60.7% | 0.00% | – |
Q3 2020 | $351,000 | -76.6% | 57,860 | -67.8% | 0.00% | – |
Q2 2020 | $1,498,000 | +184.8% | 179,448 | +102.7% | 0.00% | – |
Q1 2020 | $526,000 | +42.9% | 88,518 | +55.9% | 0.00% | – |
Q4 2019 | $368,000 | +247.2% | 56,776 | +157.6% | 0.00% | – |
Q3 2019 | $106,000 | -84.5% | 22,040 | -61.1% | 0.00% | – |
Q1 2018 | $686,000 | – | 56,707 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |